Debridement and Functional Endoscopic Sinus Surgery
Launched by ST. PAUL'S HOSPITAL, CANADA · Sep 16, 2019
Trial Information
Current as of June 16, 2025
Unknown status
Keywords
ClinConnect Summary
Purpose The purpose of this study is to assess the efficacy of post-FESS nasal debridements in the prevention of post-operative synechiae formation.
Hypothesis There is no difference in short and long term clinical outcomes between patients who had routine post-operative nasal debridement following FESS and patients who did not have post-operative nasal debridement.
Justification To prevent synechiae formation, many studies have been published evaluating the efficacy of post-operative debridement procedures. Many of these studies have shown conflicting results. There were many inconsisten...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over the age of 19;
- • Have chronic sinus disease (CRS) and are scheduled to undergo sinus surgery on both sides of your nose for the first time.
- Exclusion Criteria:
- • Unable to speak English;
- • Are having surgery for the removal of a nasal tumor;
- • Have a disorder of your immune system in which your body's immune system attacks itself (autoimmune disorder)
- • Diagnosed with cystic fibrosis
- • Have had sinus surgery in the past
- • Are scheduled to have a procedure known as nasal septal reconstruction, without additional sinus surgery
About St. Paul's Hospital, Canada
St. Paul's Hospital, located in Vancouver, Canada, is a leading healthcare institution renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital fosters innovative studies across various medical fields, focusing on translating research findings into effective treatments. With a multidisciplinary team of experienced clinicians and researchers, St. Paul's Hospital emphasizes collaboration and ethical standards, ensuring that trials are conducted with the utmost integrity and patient safety. The institution is dedicated to enhancing health outcomes through rigorous scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials